X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Glenmark Pharma with FDC LTD. - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GLENMARK PHARMA vs FDC LTD. - Comparison Results

GLENMARK PHARMA    Change

Glenmark's focus areas are dermatology, gynecology, pediatrics and diabetics. The domestic formulations business contributed about 35% to revenues in FY07. On the international front, besides exports to the semi-regulated markets, the company has bee... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    GLENMARK PHARMA FDC LTD. GLENMARK PHARMA/
FDC LTD.
 
P/E (TTM) x 12.3 21.1 58.1% View Chart
P/BV x 3.2 4.4 73.6% View Chart
Dividend Yield % 0.4 1.1 34.7%  

Financials

 GLENMARK PHARMA   FDC LTD.
EQUITY SHARE DATA
    GLENMARK PHARMA
Mar-17
FDC LTD.
Mar-14
GLENMARK PHARMA/
FDC LTD.
5-Yr Chart
Click to enlarge
High Rs993144 692.0%   
Low Rs72979 923.2%   
Sales per share (Unadj.) Rs325.547.6 684.4%  
Earnings per share (Unadj.) Rs39.37.6 516.4%  
Cash flow per share (Unadj.) Rs48.79.0 540.1%  
Dividends per share (Unadj.) Rs2.002.25 88.9%  
Dividend yield (eoy) %0.22.0 11.5%  
Book value per share (Unadj.) Rs159.247.5 334.9%  
Shares outstanding (eoy) m282.17177.83 158.7%   
Bonus/Rights/Conversions ESOPBB-  
Price / Sales ratio x2.62.3 113.1%   
Avg P/E ratio x21.914.6 149.9%  
P/CF ratio (eoy) x17.712.3 143.3%  
Price / Book Value ratio x5.42.3 231.1%  
Dividend payout %5.129.6 17.2%   
Avg Mkt Cap Rs m242,99119,784 1,228.2%   
No. of employees `00013.0NA-   
Total wages/salary Rs m16,4081,221 1,344.4%   
Avg. sales/employee Rs Th7,083.9NM-  
Avg. wages/employee Rs Th1,265.4NM-  
Avg. net profit/employee Rs Th855.1NM-  
INCOME DATA
Net Sales Rs m91,8578,459 1,086.0%  
Other income Rs m374394 94.9%   
Total revenues Rs m92,2308,852 1,041.9%   
Gross profit Rs m20,3672,070 983.8%  
Depreciation Rs m2,644249 1,061.3%   
Interest Rs m2,37331 7,653.0%   
Profit before tax Rs m15,7242,184 720.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m0-225 0.0%   
Extraordinary Inc (Exp) Rs m-8100-   
Tax Rs m3,827606 632.0%   
Profit after tax Rs m11,0881,353 819.4%  
Gross profit margin %22.224.5 90.6%  
Effective tax rate %24.327.7 87.8%   
Net profit margin %12.116.0 75.5%  
BALANCE SHEET DATA
Current assets Rs m68,7464,355 1,578.5%   
Current liabilities Rs m27,0271,792 1,508.3%   
Net working cap to sales %45.430.3 149.9%  
Current ratio x2.52.4 104.7%  
Inventory Days Days8544 191.2%  
Debtors Days Days9625 387.3%  
Net fixed assets Rs m24,1323,025 797.8%   
Share capital Rs m282179 158.0%   
"Free" reserves Rs m44,6438,243 541.6%   
Net worth Rs m44,9258,453 531.5%   
Long term debt Rs m45,36311 423,957.0%   
Total assets Rs m117,63910,557 1,114.3%  
Interest coverage x7.671.4 10.7%   
Debt to equity ratio x1.00 79,770.5%  
Sales to assets ratio x0.80.8 97.5%   
Return on assets %11.413.1 87.3%  
Return on equity %24.716.0 154.2%  
Return on capital %19.123.5 81.4%  
Exports to sales %013.3 0.0%   
Imports to sales %03.3 0.0%   
Exports (fob) Rs mNA1,126 0.0%   
Imports (cif) Rs mNA283 0.0%   
Fx inflow Rs m56,1521,146 4,899.4%   
Fx outflow Rs m8,084355 2,275.3%   
Net fx Rs m48,068791 6,078.3%   
CASH FLOW
From Operations Rs m6,5741,485 442.7%  
From Investments Rs m-7,124-620 1,149.9%  
From Financial Activity Rs m5,432-753 -721.8%  
Net Cashflow Rs m1,992113 1,766.3%  

Share Holding

Indian Promoters % 48.3 68.9 70.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 6.9 4.7 146.8%  
FIIs % 34.4 7.5 458.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 10.5 19.0 55.3%  
Shareholders   56,727 23,730 239.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare GLENMARK PHARMA With:   ORCHID PHARMA LTD  CIPLA  TORRENT PHARMA  SUVEN LIFE  WYETH LTD  

Compare GLENMARK PHARMA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes Firm on Exit Polls; Metal Stocks Rise(Closing)

Indian share markets witnessed buying momentum in today's session after exit polls predicted a BJP victory in Gujarat and Himachal Pradesh.

Related Views on News

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

Glenmark: Zetia Bolsters Sales and Profits (Quarterly Results Update - Detailed)

Oct 30, 2017

The 180-day exclusivity for Zetia enabled Glenmark to show strong growth in sales and profits during the quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

More Views on News

Most Popular

Using Deposits to Rescue Banks is a Bad Idea; It Needs to Be Nipped in the Bud(Vivek Kaul's Diary)

Dec 11, 2017

The Financial Resolution and Deposit Insurance(FRDI) Bill proposes to do just this.

If You're Not Looking for 'Excitement' but 'Big Returns' from Stocks, This Is for You(The 5 Minute Wrapup)

Dec 7, 2017

One does not have to necessarily invest only in 'exciting' stocks to become wealthy.

Beat Fund Managers at Their Own Game with These Stocks(Smart Contrarian)

Dec 6, 2017

The road to big investment gains passes through this universe.

NASA on Aliens and Bitcoin(The Honest Truth)

Dec 14, 2017

The most hilarious scam that aliens have ever planted on Planet Earth.

A Month To Go, Have You Linked Your Aadhaar?(Outside View)

Dec 4, 2017

PersonalFN tells you how to link Aadhaar to to various documents and services.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

GLENMARK PHARMA SHARE PRICE


Dec 15, 2017 (Close)

TRACK GLENMARK PHARMA

  • Track your investment in GLENMARK PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON GLENMARK PHARMA

GLENMARK PHARMA - GSK PHARMA COMPARISON

COMPARE GLENMARK PHARMA WITH

MARKET STATS